Merck & Co., Inc.
MRK
Rankning i aktier
#38
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Aktiekurs
$148.36
Senast synkroniserad: 2026-10-20
Marknadsvärde
$366.03B
Förändring (1 dag)
3.31%
Förändring (1 år)
69.32%
Land
US
Handel Merck & Co., Inc. (MRK)
Kategori
Healthcare
Vinst för Merck & Co., Inc. (MRK)
Vinst i Jun 2026 TTM: $5.95B
Enligt de senaste finansiella rapporterna från Merck & Co., Inc. är företagets nuvarande vinst $5.95B. År 2024 hade företaget en vinst på $19.94B, en ökning jämfört med vinsten år 2023 som var $1.89B. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Merck & Co., Inc. från 2000 till 2026
Vinst vid slutet av varje år
| År | Vinst | Ändra |
|---|---|---|
| 2026 (TTM) | $5.95B | -71.77% |
| 2025 | $21.07B | 5.67% |
| 2024 | $19.94B | 955.37% |
| 2023 | $1.89B | -88.51% |
| 2022 | $16.44B | 18.48% |
| 2021 | $13.88B | 136.72% |
| 2020 | $5.86B | -18.24% |
| 2019 | $7.17B | -17.58% |
| 2018 | $8.70B | 33.43% |
| 2017 | $6.52B | 39.97% |
| 2016 | $4.66B | -13.74% |
| 2015 | $5.40B | -68.75% |
| 2014 | $17.28B | 211.69% |
| 2013 | $5.55B | -36.55% |
| 2012 | $8.74B | 19.16% |
| 2011 | $7.33B | 343.68% |
| 2010 | $1.65B | -89.19% |
| 2009 | $15.29B | 53.96% |
| 2008 | $9.93B | 194.63% |
| 2007 | $3.37B | -45.82% |
| 2006 | $6.22B | -15.51% |
| 2005 | $7.36B | -7.98% |
| 2004 | $8.00B | -11.59% |
| 2003 | $9.05B | -6.22% |
| 2002 | $9.65B | -2.98% |
| 2001 | $9.95B | 1.26% |
| 2000 | $9.82B | 0.00% |
Vinst för liknande företag eller konkurrenter
| Företag | Vinst | Skillnad i vinst | Land |
|---|---|---|---|
| $33.60B | 464.82% |
US
|
|
| $17.74B | 198.20% |
US
|
|
| $8.70B | 46.25% |
US
|
|
| $21.39B | 259.59% |
CH
|
|
| $16.38B | 175.36% |
CH
|
